Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Pirisi

Showing results (231-240 of 236) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 236 results.
Liver International : Official Journal of the International Association for the Study of the Liver|July 29, 2025
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian ParadigmGian Paolo Caviglia, Eleonora Dileo, Antonella Olivero, et al.
Hepatology (Baltimore, Md.)|July 19, 2024
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatmentCiro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, et al.
Journal of Hepatology|June 15, 2026
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinomaPasquale Lombardi, Erik Ramon-Gil, Rabial Q Raja, et al.
The Lancet. Digital Health|February 13, 2026
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort studyMathew Vithayathil, Giulia Francesca Manfredi, Antonio D'Alessio, et al.
Scientific Reports|November 27, 2020
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patientsMattia Bellan, Giuseppe Patti, Eyal Hayden, et al.
Disease Markers|May 31, 2021
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19Mattia Bellan, Danila Azzolina, Eyal Hayden, et al.
Pageof 24

Showing results (231-240 of 236) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 236 results.
Liver International : Official Journal of the International Association for the Study of the Liver|July 29, 2025
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian ParadigmGian Paolo Caviglia, Eleonora Dileo, Antonella Olivero, et al.
Hepatology (Baltimore, Md.)|July 19, 2024
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatmentCiro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, et al.
Journal of Hepatology|June 15, 2026
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinomaPasquale Lombardi, Erik Ramon-Gil, Rabial Q Raja, et al.
The Lancet. Digital Health|February 13, 2026
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort studyMathew Vithayathil, Giulia Francesca Manfredi, Antonio D'Alessio, et al.
Scientific Reports|November 27, 2020
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patientsMattia Bellan, Giuseppe Patti, Eyal Hayden, et al.
Disease Markers|May 31, 2021
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19Mattia Bellan, Danila Azzolina, Eyal Hayden, et al.
Pageof 24